SOHO Brazil 2024

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

SOHO Brazil 2024

Videos

Playback speed

10 seconds

1L Therapy in CLL: What Are the Best Options?

By SOHO Brazil 2024 FEATURING Jan Burger

830 views

July 11, 2024

Chapters

Efficacy of BTK Inhibitors & Venetoclax

00:00

Long-Term Data on Ibrutinib Monotherapy

03:17

Comments 0

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Videos

SOHO Brazil 2024: Treatment of Primary CNS Lymphoma

SOHO Brazil 2024

A. Alencar

105 views

Summary of Recent Updates in Advanced Hodgkin Lymphoma

SOHO Brazil 2024

C. Moskowitz

198 views

Where I Use Azacitidine and Venetoclax in AML: Present and Future

SOHO Brazil 2024

J. Lancet

463 views

1L Therapy in CLL: What Are the Best Options?

SOHO Brazil 2024

J. Burger

830 views

Managing Infectious Complications With Bispecific and CAR-T Therapy …

SOHO Brazil 2024

N. S. Raje

193 views

When to Consider Bispecific and CAR-T Therapy in MM

SOHO Brazil 2024

N. S. Raje

401 views

Frontline MM: Are Four Better Than Three?

SOHO Brazil 2024

N. S. Raje

79 views

FL: How Do I Deal With Relapse?

SOHO Brazil 2024

B. Kahl

462 views

To 2L and Beyond: Treatment Options in R/R MCL

SOHO Brazil 2024

T. Phillips

32 views

FL Updates: Is There a Standard 1L Treatment?

SOHO Brazil 2024

B. Kahl

304 views

3L in CLL: The Best Options in a Patient Double-Refractory to Covale…

SOHO Brazil 2024

J. Burger

493 views

Single vs. Multiple Agents in 2L Therapy for CLL

SOHO Brazil 2024

J. Burger

343 views

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

503 views

Are We Closer to Conquering HR-MDS?

SOHO Brazil 2024

R. Komrokji

97 views

Therapies on the Horizon in LR- and HR-MDS

SOHO Brazil 2024

R. Komrokji

150 views

What Is the Best Timing for Bispecific Antibodies and CAR-T Therapy …

SOHO Brazil 2024

A. Zelenetz

57 views

DLBCL Pts Ineligible for CAR-T Therapy: Do They Exist and How Do We …

SOHO Brazil 2024

A. Zelenetz

126 views

Summary of Updates in R/R DLBCL Treatment

SOHO Brazil 2024

A. Alencar

108 views

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

556 views

Summary of Recent Updates in R/R HL

SOHO Brazil 2024

C. Moskowitz

124 views

Summary of Recent Updates on LR-MDS Management

SOHO Brazil 2024

R. Komrokji

44 views

How Are Targeted Therapies Redefining the Treatment Paradigm in ALL …

SOHO Brazil 2024

J. Burger

119 views

Early Stage HL: Can Radiation Therapy Be Eliminated?

SOHO Brazil 2024

C. Moskowitz

110 views

PNH: Summary of Latest Advancements and Case Discussion

SOHO Brazil 2024

B. Fattizzo

242 views

The Gold Standard in the Use of FLT3 and IDH Inhibitors in AML

SOHO Brazil 2024

J. Lancet

135 views

Making Sense of 1L Treatment Options in MCL

SOHO Brazil 2024

T. Phillips

115 views